XML 109 R77.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Deficit (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 28, 2019
Jul. 25, 2019
Sep. 30, 2019
Mar. 31, 2020
Mar. 31, 2019
Stockholders' Deficit (Textual)          
Intrinsic value of warrants outstanding and exercisable       $ 200  
Common stock, authorized       500,000,000 500,000,000
Preferred stock, authorized       10,000,000 10,000,000
Preferred stock, par value (in dollars per share)       $ 0.001 $ 0.001
Aggregate number of shares of capital stock authority to issue shares       501,000,000  
Sale of common stock shares   5,000,000      
Common stock price per share   $ 2.10      
Common stock gross proceeds   $ 10,500      
Common stock net proceeds $ 150,000 9,500      
Common stock offering costs   $ 1,000      
Consultants [Member]          
Stockholders' Deficit (Textual)          
Common restricted stock issued for services, value       $ 4,200 $ 2,200
Common restricted stock issued for services, shares       1,709,146 449,374
Expense related to restricted stock issuances       $ 3,300 $ 3,100
Employees [Member]          
Stockholders' Deficit (Textual)          
Common restricted stock issued for services, shares       0 0
Expense related to restricted stock issuances       $ 100 $ 500
Unrecognized compensation cost        
Music Partner [Member]          
Stockholders' Deficit (Textual)          
Common restricted stock issued for services, value     $ 400    
Common stock price per share     $ 4.51    
Options Grants to Employees [Member]          
Stockholders' Deficit (Textual)          
Unrecognized compensation cost       $ 1,100  
Expected life       7 years 9 months 18 days  
Recognized share-based compensation expense to employees       $ 2,500 7,200
Tax benefit recognized share-based compensation expense       $ 0 0
Weighted-average remaining contractual term       7 years 9 months 18 days  
Options to employees exercisable       7 years 9 months 18 days  
Intrinsic value of options outstanding       $ 4,400  
Intrinsic value of options exercisable       3,200  
Options Grants to Non-Employees [Member]          
Stockholders' Deficit (Textual)          
Recognized share-based compensation expense to employees       100 100
Tax benefit recognized share-based compensation expense       $ 0 0
Weighted-average remaining contractual term       7 years 10 months 25 days  
Intrinsic value of options outstanding       $ 0  
Intrinsic value of options exercisable       0  
Restricted Stock Units Grants [Member]          
Stockholders' Deficit (Textual)          
Unrecognized compensation cost       6,700  
Recognized share-based compensation expense to employees       5,400 2,100
Tax benefit recognized share-based compensation expense       $ 0 $ 0
Weighted-average remaining contractual term       1 year 9 months 18 days  
Restricted stock awards [Member]          
Stockholders' Deficit (Textual)          
Unrecognized compensation cost       $ 100  
Expected life       10 months 25 days  
Weighted average grant date fair value per share of awards issued         $ 4.05
Recognized share-based compensation expense to employees       $ 100 $ 0
Tax benefit recognized share-based compensation expense       $ 0 $ 0
2016 Equity Incentive Plan [Member]          
Stockholders' Deficit (Textual)          
Reserves total of common stock shares for issuance       12,600,000  
Common stock shares available for future issuance       2,446,270  
Maximum contractual term       10 years